Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C S Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112724110B details a novel nickel-catalyzed route for VEGFR inhibitor intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN117362140B reveals high-yield photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113980028A reveals a mild oxidative coupling method for chiral spiro indolones, offering scalable routes for reliable pharmaceutical intermediate suppliers.
Patent CN113072478B details a mild copper-catalyzed N-arylation method using aryl silanes, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN111662147A reveals a green copper-catalyzed method for diacetylenes, offering cost reduction and scalable manufacturing for pharmaceutical and material science applications.
Patent CN111848480A details a copper-catalyzed method for synthesizing aryl difluoromethylselenyl ethers from boronic acids, offering cost-effective routes for drug discovery.
Patent CN119462473B details a nickel-catalyzed route for pyrrolidine units, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111662147B reveals a mild Cu-catalyzed route for diynes. This method offers significant cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
Patent CN102964271B details a novel one-step Pd-catalyzed synthesis of 2-cyano-4'-methylbiphenyl, offering significant cost reduction and scalability for sartan drug manufacturers.
Patent CN113636968B introduces a ruthenium-catalyzed route for synthesizing pharmaceutical intermediates with exceptional atom economy and simplified manufacturing processes.
Novel ruthenium-catalyzed method enables high-purity 3-acylpyrrole production with enhanced supply chain reliability and significant cost reduction potential for pharmaceutical intermediates.
Innovative copper(I)-catalyzed method for 1,3-enyne synthesis eliminates expensive palladium, offering high purity and scalable production for pharmaceutical intermediates.
This patent introduces a novel ruthenium-catalyzed alcohol-hydrogen transfer coupling method for synthesizing structurally diverse 3-acylpyrrole compounds with exceptional atom economy and simplified purification protocols enabling reliable supply chain solutions.
Patent CN113735752B introduces a novel metal-free C-S coupling method for high-purity isothiourea intermediates with enhanced supply chain reliability and significant cost reduction potential.
Novel indole-skeleton phosphine ligand enables high-yield C-S bond formation with reduced catalyst loading, offering significant supply chain reliability for pharmaceutical intermediates.
Patent CN113651738A enables metal-free synthesis of diphenyl sulfide compounds with enhanced purity and scalable production for pharmaceutical supply chains.
Novel ruthenium-catalyzed one-pot synthesis achieves high atom economy and operational simplicity for critical pharmaceutical intermediates with enhanced supply chain reliability.
Breakthrough intramolecular cross-dehydrogenation coupling method enables efficient production of coumarin heteroaromatic compounds with significant cost reduction and enhanced supply chain reliability.
Patent CN113636968B enables high-purity API intermediates through ruthenium-catalyzed synthesis with enhanced atom economy and reduced manufacturing costs.